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ABSTRACT
MicroRNA (miRNA)-mediated gene regulation has
become a major focus in many biological
processes. GW182 and its long isoform TNGW1 are
marker proteins of GW/P bodies and bind to
Argonaute proteins of the RNA induced silencing
complex. The goal of this study is to further define
and distinguish the repression domain(s) in human
GW182/TNGW1. Two non-overlapping regions, "12
(amino acids 896–1219) containing the Ago hook and
"5 (amino acids 1670–1962) containing the RRM,
both induced comparable silencing in a tethering
assay. Mapping data showed that the RRM and its
flanking sequences in "5, but not the Ago hook in
"12, were important for silencing. Repression
mediated by "5o r"12 was not differentially
affected when known endogenous repressors
RCK/p54, GW182/TNGW1, TNRC6B were depleted.
Transfected "5, but not "12, enhanced
Ago2-mediated repression in a tethering assay.
Transfected "12, but not "5, released endogenous
miRNA reporter silencing without affecting siRNA
function. Alanine substitution showed that GW/WG
motifs in "12 ("12a, amino acids 896–1045) were im-
portant for silencing activity. Although "12 appeared
to bind PABPC1 more efficiently than "5, neither "5
nor "12 significantly enhanced reporter mRNA deg-
radation. These different functional characteristics
of "5 and "12 suggest that their roles are distinct,
and possibly dynamic, in human GW182-mediated
silencing.
INTRODUCTION
MicroRNAs (miRNA) are endogenous 20–25nt RNAs
largely transcribed from independent miRNA genes or
gene clusters and play many key roles in a variety of
normal and pathological cellular processes (1). MiRNAs
are incorporated into the RNA-induced silencing complex
(RISC) to effect translational repression or RNA degrad-
ation of their target mRNAs (2–6). The Argonaute protein
family, a highly conserved key component of the RISC
complex, is represented by four proteins (Ago1–Ago4) in
mammals that are involved in miRNA-mediated transla-
tional silencing (7). Only Ago2 harbors RNase H-type
activity in its C-terminal P-element induced wimpy testis
(PIWI) domain and is known to function in small
interfering RNA (siRNA)-mediated slicing of mRNA
targets by endonucleolytic cleavage (8–10).
GW182 (Gene name TNRC6A) was ﬁrst identiﬁed and
characterized by our laboratories in 2002 as a novel
protein recognized by an autoimmune serum from a
patient with motor and sensory neuropathy (11). It is an
182-kDa protein characterized by multiple glycine (G) and
tryptophan (W) motifs and is an essential component of
GW bodies (also known as mammalian processing bodies,
or P bodies) (6,12). Two isoforms of GW182, named
TNGW1 (long isoform) and GW182 (short isoform) re-
spectively, have been subsequently reported with TNGW1
being identical in sequences with GW182 but has addition-
al N-terminal 253 amino acids containing trinucleotide
glutamine-repeat (TNR Q-repeat) domain (13). In the
GW182 family, there are three paralogs of TNRC6
(GW182-related) proteins comprising GW182/TNGW1,
TNRC6B (containing three isoforms) and TNRC6C in
mammal, a single Drosophila ortholog (dGW182, also
known as Gawky) and two Caenorhabditis elegans
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to play a critical role in the silencing and degradation of
miRNA-targeted mRNAs across different species
(13,16–35). Signiﬁcant progress has been made in
characterizing the 30-UTR sequence element required for
efﬁcient targeting and regulation of miRNA (36,37) but
the detailed molecular basis of the miRNA-mediated
translational silencing and mRNA degradation, especially
with respect to their role of human GW182/TNGW1, is
not completely understood (1,5,14–16). The Argonaute
proteins, including Ago1–Ago4, are the most highly
characterized factors in the miRNA-induced silencing
complex (miRISC), where they bind miRNA to mediate
recognition of target mRNAs (38,39). Argonaute proteins
artiﬁcially tethered to the mRNA 30-UTR induce transla-
tional silencing (25,40,41). However, the Ago–miRNA/
mRNA complex requires recruitment of additional
protein factors to effect subsequent translational repres-
sion (13,21,42). Multiple candidates have been proposed
to play an important role in the miRNA-mediated trans-
lational silencing. Among these, GW182 is a conserved
factor that retains a key role in miRNA-mediated trans-
lational repression and mRNA degradation across differ-
ent species, as evidenced by studying of GW182 proteins
in humans (17,23–26,28–30,33), Drosophila
(18–22,27,31,42) and C. elegans (35,43). An important
feature of the GW182 family in this process is its
conserved ability to bind with Ago proteins
(17,20,21,24–26,28,31–34,43). In addition, the GW182
family is shown to induce translational silencing effect
despite the absence of Ago2 (13,20,25,31). Knockdown
of individual GW182 related proteins by speciﬁc siRNAs
only partially rescue the repression indicating the func-
tional redundancy among those paralogs (28). However,
they appear not to have identical roles in repression as
TNRC6B and TNRC6C form distinct protein complexes
with the four human Argonaute proteins (17).
Signiﬁcant efforts have been made to map the repres-
sion domains of human (17,24,28) and Drosophila
GW182-related proteins (18–20,22). The C-terminal
domain including the domain of unknown function
(DUF), M-GW, RRM and C-GW is commonly identiﬁed
as the ‘silencing domain’ in a variety of species. However,
it is controversial and remains to be conﬁrmed if the
‘N-terminal Ago-binding domain’ spanning the N-GW
region possesses full silencing effects (18,19), is partially
active (28) or completely inactive (17,20,24), albeit these
studies use slightly different deletion construct boundaries
and/or different species.
In the current study, mapping of the repression
domain(s) of human GW182 was performed by generating
a series of deletion constructs covering the full-length
GW182 protein. Two non-overlapping domains, a
middle GW182 fragment 12 (amino acids 896–1219)
and a C-terminal GW182 fragment 5 (amino acids
1670–1962), were shown to trigger translational silencing
when tethered to the 30-UTR. We showed that these
domains representing the minimum length of middle-
and C-terminal deletion constructs caused comparable
silencing effects on the reporter compared to two
full-length GW182 isoforms, TNGW1 and GW182.
The present study deﬁned a novel silencing domain on
human GW182 and the role of GW/WG motifs within
this domain.
MATERIALS AND METHODS
Plasmids
The cDNAs of TNGW1, GW182, TNR, 1, 10, 12,
7, 8, 5, Ago2 and PIWI were constructed as
described in our previous studies (6,13,25). The
N-terminal construct ‘1–565’ was generated by restriction
digestion using enzymes HpaI and SmaI to excise the 30
fragment from the full-length construct pENTR-TNGW1;
the construct was completed by T4 DNA ligase reaction to
re-circularize the truncated linearized plasmid. 5a, 5b,
8 and 11 were generated by polymerase chain reaction
(PCR) using GW182 cDNA as the template. The PCR
cloning primers were: 5a, forward 50-AAAAAGCAGG
CTCCTCATCCTTGAACACCACG-30, reverse 50-AGA
AAGCTGGGTTCAGCTGGAACCTGGGGTATATC
T-30; 5b, forward 50-AAAAAGCAGGCTCCTCATCC
TTGAACACCACG-30, reverse 50-AGAAAGCTGGGTT
CAGTCTCCACAGTTAGTTCCCGACA-30; 8,
forward 50-GGGGACAAGTTTGTACAAAAAAGCAG
GCTTCATTAGACAGAATGGCAATCC-30, reverse
50-GGGGACCACTTTGTACAAGAAAGCTGGGTTA
GGCAACATCAAGGCATAG-30; 11, forward 50-AAA
AAGCAGGCTTCACTTGGGGAAACAACATA-30,
reverse 50-AGAAAGCTGGGTTCACTCTGGTGAGTC
TCTCGAAAA-30. Fragments 12a and 12b were
directly synthesized by GenScript Corp (Piscataway, NJ,
USA). The cDNA of 12a mutant (12am, all GW or
WG changed to AA) was also synthesized by GenScript.
The PABPC1 expression vector was purchased from
OriGene (Rockville, MD, USA). All of the variants used
in current study were subcloned into the Gateway destin-
ation vector for GST, green ﬂuorescence protein (GFP),
or hemagglutinin tagged with a 22-amino-acid-long N
peptide speciﬁcally recognizing the BoxB hairpin (NHA)
(13) expression using the Gateway LR recombination
reaction (Invitrogen, Carlsbad, CA). The tethering assay
plasmids, including pCIneo-NHA vector, NHA-Ago2,
Renilla luciferase (RL) and ﬁreﬂy luciferase (FL), with
or without the 5BoxB structure in the 30-UTR, were
obtained from Dr Witold Filipowicz, Friedrich Miescher
Institute for Biomedical Research, Basel, Switzerland (40).
The miR20 luciferase reporter RL-20 bulge and RL-20
perfect was obtained from Dr Phillip Sharp,
Massachusetts Institute of Technology (44). All DNA
constructs used in this study were conﬁrmed by direct
DNA sequencing.
Antibodies
Rabbit polyclonal anti-GST and RCK/p54 were
purchased from MBL International (Woburn, MA,
USA). Mouse monoclonal anti-HA was purchased from
Covance (Emeryville, CA, USA). Mouse monoclonal
anti-tubulin was purchased from Santa Cruz
Biotechnology (Santa Cruz, CA, USA).
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HeLa, A549 and HEK293 cells were cultured in DMEM
containing 10% fetal bovine serum in a 37 C incubator
with 5% CO2. The plasmid transfection was performed
using Lipofectamine 2000 (Invitrogen) as per the
manufacturer’s instruction. The tethering assays were per-
formed in a 24-well plate format. Six hundred nanograms
of NHA-GW182 construct were co-transfected with either
10ng RL-5BoxB/100ng FL or 100ng FL-5BoxB/10ng
RL in HEK293 cells. Cells were harvested 48h after trans-
fection for luciferase assays. For the GST pull-down
assays, 2mg of GST-tagged GW182 construct was
co-transfected with 2mg NHA-tagged construct into
HeLa cells. HeLa cells were harvested 24h after transfec-
tion, lysed by NET/NP40 buffer (150mM NaCl, 5mM
EDTA, 50mM Tris, pH 7.4, 0.3% NP40) with Complete
Protease Cocktail Inhibitor (Roche Diagnostics,
Indianapolis, IN, USA), and then applied to GST
pull-down assays.
GST pull-down assays and western blot analysis
Cell lysates were sonicated at 20% amplitude for 10s three
times on ice and then centrifuged at 13200rpm for 5min.
A fraction of soluble lysate was mixed with Laemmli
sample buffer as input for western blot analysis. Two hun-
dredmicro liters of the soluble fractions were incubated
with Glutathione Sepharose 4B (GE Healthcare,
Piscataway, NJ, USA) and mixed at 4 C for 2h for
GST pull-downs. After the incubation, the beads were
washed with NET/0.3% NP40 buffer four times and the
samples were eluted in Laemmli sample buffer. The input
and GST pull-down samples were separated on 10% poly-
acrylamide gels and transferred to nitrocellulose and
western blotting performed as described previously (45).
The dilutions of primary antibodies were: 1:1000 for
anti-GST, and 1:1000 for anti-GFP.
Micrococcal nuclease assay
Three parallel transfections in HeLa cells were set up with
indicated combinations of GST-PIWI and NHA-tagged
constructs. Whole cell lysates were harvested in
EDTA-free lysis buffer containing 150mM NaCl and
EDTA-free Protease Cocktail Inhibitor (Roche
Diagnostics, Indianapolis, IN, USA) 24h after transfec-
tion. Samples (200ml) were diluted in equal volume of the
same buffer without NaCl to adjust to a ﬁnal concentra-
tion of 75mM NaCl. Untreated group was immediately
transferred on ice until ready for the pull-down assay.
Mock and micrococcal nuclease (MNase) treated groups
were added 10ml 0.1M CaCl2. A total of 0.2U MNase
(Sigma, St. Louis, MO) was added only to the MNase
treated group. Both Mock and MNase groups were
incubated in 37 C for 10min. Twenty microliters of
0.5M EGTA was added to inactivate MNase. An
aliquot of cell lysate from each group were separated for
RNA extraction using mirVana total RNA isolation kit
(Applied Biosystems, Foster City, CA, USA). All three
groups were subjected to GST pull-down assay protocol
described above.
Tethering assay and miRNA interference assay using a
dual luciferase assay
HEK293 cells were harvested 48h after transfection with
tethering constructs and dual luciferase reporters. The FL
and RL activities were measured using the Dual-
Luciferase Reporter Assay System (Promega, Madison,
WI, USA) following the manufacturer’s protocol. Relative
luciferase activities were calculated as the ratio of targeted
luciferase activities over control luciferase activities (40).
The repression levels of experimental groups were
calculated by the percentage reduction of relative
luciferase activities compared with that in the NHA
control group (13). The relative repression effects of
all constructs were normalized to that of NHA, which
was standardized as 1. Data for each construct were col-
lected in 6–18 replicates. HeLa and A549 adenocarcinoma
human alveolar basal epithelial cells were also used to
address any cell speciﬁc effects. For miRNA interference
assays, RL-20 bulge and RL-20 perfect, containing seven
copies of miR-20 target sites at the 30-UTR which form
imperfect or perfect matches with endogenous miR-20
were co-transfected into HEK293, HeLa and A549 cells
with FL internal control and tested constructs. Luciferase
activities were measured as described above. Cell lysates
from representative luciferase assays were mixed directly
with Laemmli sample buffer and separated in 4–20%
HCl–Tris Ready Gels (BioRad, Hercules, CA, USA) to
quantify the expression levels of different NHA-tagged
GW182 constructs. Samples were then transferred to
nitrocellulose membranes and analyzed by western blot
using anti-HA tag antibody. To avoid the relatively
narrow dynamic range of traditional ﬁlm systems, bands
visualized by an enhanced chemiluminescence assay were
captured with a Geliance 600 (PerkinElmer, Waltham,
MA, USA) to obtain optimal images. The results were
then analyzed by GeneTools software (PerkinElmer) or
Image J (http://rsbweb.nih.gov/ij/) to quantify the
amount of protein expressed in individual assays.
siRNA and qRT–PCR
HeLa cells were seeded at a concentration of 5 10
4 cells/
well into 24-well plates in 0.5ml culture medium.
siGENOME SMARTpool siRNA for GFP, GW182
(NM_014494) and TNRC6B (NM_015088) or RCK/p54
(NM_004397) were purchased from Dharmacon, Inc
(Lafayette, CO). The ﬁnal concentration used for trans-
fection was 100nM. Four different duplexes of GW182
siGENOME siRNA were purchased separately from
Dharmacon (Cat No. D-014107-01–D-014107-04). Since
duplex 1 targets sequences common in 5, only duplexes
2–4 were used to knockdown endogenous GW182 in ex-
periments when the co-expression of 12 or 5 was
required. To monitor the efﬁciency of the siRNA
knockdown, parallel experimental groups were set up.
Total RNA samples were harvested using mirVana total
RNA isolation kit (Applied Biosystems) 48h after siRNA
transfection following the manufacturer’s instructions.
Reverse transcription was performed using High
Capacity cDNA Reverse Transcription Kit (Applied
Biosystems). The relative mRNA levels of target genes
2536 Nucleic Acids Research, 2011,Vol.39, No. 7were measured in duplicate using TaqMan Fast Universal
Master Mix (Applied Biosystems) with the corresponding
TaqMan Gene Expression Assay (Applied Biosystems).
Quantiﬁcation of mRNA degradation using SYBR-
Green quantitative real time polymerase chain reaction
(qRT–PCR) was described previously (13).
RESULTS
Non-overlapping GW182 fragments "12 and "5 harbored
comparable repression effects to full-length GW182/
TNGW1
As shown in Figure 1A, human GW182 and its longer
isoform TNGW1 (13) contain three glycine/tryptophan
(GW)-rich regions in their N-terminal, middle and
C-terminal domains (N-GW, M-GW and C-GW, respect-
ively), as well as an RNA recognition motif (RRM, amino
acids 1780–1853, cd00590). Another interesting domain is
a short sequence element termed the ‘Argonaute hook’
(Ago hook, amino acids 1076–1144, pfam10427) that
binds to PIWI domains of Ago proteins (34). There is
also a short stretch of glutamine repeats in the
N-terminal domain of TNGW1 [trinucleotide repeat
(TNR) Q-repeat, amino acids 93–127] (13) and a glutam-
ine/asparagine-rich region (Q/N-rich, amino acids 1264–
1553) between the N-GW and M-GW regions (46). A
conserved ubiquitin-associated domain (UBA) (31) and
another DUF (amino acids 1604–1641) (23,28) are also
shown in recent reviews (14,15). Right after reporting
our ﬁndings that human GW182 induced silencing inde-
pendent of Ago2 (13), the current study was initiated with
multiple truncated constructs of GW182 spanning the
full-length protein (Figure 1) to narrow down the region
responsible for the repression effect in the tethering assay.
These constructs were adapted to the tethering assay
(13,40) and examined for their repression effects accord-
ingly. As shown in the right panel, the relative repression
effects observed for different GW182-truncated constructs
was sorted into three categories: (i) no repression effect
including 1–565, TNR, 1 and QN; (ii) high repression
effect comparable to full length protein including 10,
12, 8, 7 and 5; (iii) 11, which had a low to
moderate repression effect. Interestingly, the results
revealed that there were more than one non-overlapping
region able to induce a repression effect when tethered to
the 30-UTR of the reporter mRNA. GW182 fragment 12
and 5 were the smallest representative, non-overlapping
constructs that retained the most repression effect of the
full-length protein without being expressed signiﬁcantly
higher than other truncated constructs (Supplementary
Figure S1). Both FL-5BoxB and RL-5BoxB reporters
were used in these tethering assays and similar effects
were observed from using either reporter. In subsequent
studies, primarily the RL-5BoxB reporter was utilized.
Since 12 and 5 were reported to bind to Ago
proteins (25), an initial interpretation was that their re-
pression activities were related to their binding of Ago
proteins. Contradicting this hypothesis, 1, an
N-terminal truncated construct of GW182 that strongly
binds to all four human Ago proteins (25) did not show
repression in the tethering assay. This ﬁnding is consistent
with previous reports that Ago proteins were not the
direct effectors of repression (20,24). In summary, a
novel domain 12 was identiﬁed in human GW182/
TNGW1 with a comparable silencing activity to the estab-
lished silencing domain 5 and full-length GW182/
TNGW1.
Figure 1. "12 and 5 are two non-overlapping GW182 domains harboring repression in tethering function assay. The left panel shows GW182/
TNGW1 and their series of truncation constructs. Amino acid residues of GW182 constructs are referenced to TNGW1, the longer isoform of
GW182 (GenBank Accession NM_014494.2). TNR Q-repeat (green), glutamine repeat at the N-terminal domain of TNGW1; N-GW, M-GW and
C-GW (yellow), three glycine/tryptophan-rich regions; Ago hook (red), a region reported to bind Ago protein; Q/N-rich (purple), glutamine/
asparagine-rich region; DUF, DUF (orange); RRM (blue), RNA recognition motif. The right panel shows relative repression effects on reporter
(either FL-5BoxB or RL-5BoxB; data combined as no difference was observed between reporters) by tethering the corresponding construct to the
30-UTR of lucifearse mRNA. Their repression effects were normalized to NHA control, which was assigned as 1. Bar graphs show averages with
standard errors (error bars); n, numbers of repeated experiments; Asterisk represents signiﬁcant difference from NHA in t-test, P<0.01; NS, no
statistical signiﬁcance.
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reporter silencing and Ago2 binding
An intriguing ﬁnding was that the two identiﬁed GW182
domains with repression activities had different deﬁned
domains: the Ago hook domain in 12 (Figure 2A) and
the RRM domain in 5 (Figure 2B). The Ago hook has
been shown to bind to Ago2 independently in vitro but it is
not conserved in all GW182-related proteins (14,20,34).
The RRM is linked to RNA-binding activity (11) and is
highly conserved in the GW182 family. Initial experiments
were designed to examine whether the Ago hook or RRM
was important for the repression effect of 12 or 5i n
human GW182 respectively. To better evaluate the
silencing roles of these two domains, truncated constructs
were generated (Figure 2A and B). When 12 was ex-
pressed as 12a and 12b, which contain about equal
distribution of GW/WG motifs, both truncated constructs
had a signiﬁcant reduction in repression activity compared
to 12. Compared to the N-terminal half 12a, which
lacked the Ago hook but retained most of the repression
activity of 12, the C-terminal half 12b containing
the Ago hook signiﬁcantly lost the repression activity
(Figure 2A). Thus, these results showed that the Ago
hook was not critical for 12-induced repression in the
tethering assay.
To examine the importance of the RRM domain, two
C-terminal deletion constructs of 5 were generated
(Figure 2B). Fragment 5b, which contained the RRM
domain, M-GW region and part of the C-GW region,
retained repression activity when compared to 5o r
GW182/TNGW1. The repression capacity of 5a, which
contained M-GW but not the RRM domain, was signiﬁ-
cantly reduced compared to full-length 5 but still
retained  50% of repression compared to NHA control
(Figure 2B). Our data with human GW182 were consistent
with recent reports on human TNRC6C (28) and dGW182
(14,15,20,22) showing that the RRM and its ﬂanking se-
quences enriched in GW/WG motifs (M-GW and C-GW)
were pivotal for the repression, whereas the Ago hook
contributed little to the repression induced by 12.
To determine whether the observed repression activity
was correlated with the Ago-binding function, 12 or its
deletion constructs were analyzed for Ago2-binding
activity using a GST pull-down assay (Figure 2C). The
results showed that NHA-12, NHA-12a, NHA-12b
and NHA-5 were all pulled-down by GST-PIWI albeit
at different efﬁciency. For a semi-quantitative analysis,
when normalized to the pulled-down GST-PIWI levels
and compared to NHA-12, only 1.1 and 20% of the
expressed NHA-12a and NHA-12b, respectively,
were pulled down (Figure 2C). This estimation was con-
sistent with the results showing that the Ago hook alone
was insufﬁcient to achieve maximum binding to Ago2
(24,26). Intriguingly, the integrity of 12 was important
as it bound to the Ago2 PIWI domain substantially
stronger than the 12a or 12b fragments alone,
implying the full-length 12 formed a higher order struc-
ture to perform both Ago2-binding and silencing of the
bound mRNA. The positive control NHA-10 containing
Figure 2. Roles of Ago hook and RRM domains for repression in tethering function assay and binding to Ago2. (A) The Ago hook in 12 was not
critical for its repression effect. Compared to 12a which still retained 60% repression compared to NHA, 12b had only 27% repression. Results
are expressed as mean±standard error from three independent experiments. Asterisk represents signiﬁcant difference between 12a to 12 and
12a to 12b using t-test, P<0.01. (B) RRM domain and its ﬂanking sequences in 5 were required for maximal repression effect. The repression
activity of 5a was signiﬁcantly reduced to only 55% of 5 (Asterisk represents signiﬁcantly different compared to 5i nt-test, P<0.01). The
repression effect of 5b was not signiﬁcantly different from that of 5( P=0.12). Results are expressed as mean±standard error from three
independent experiments. (C) Semi-quantitative western blot analysis showed differential binding of NHA-GW182 domains to GST-PIWI in GST
pull-down assay. Bands (arrows) in blotting data were quantiﬁed and normalized to the total input (left panel) to obtain percent pull-down as shown
for each lane at the bottom of the anti-HA panel. NHA-12a, NHA-12b and NHA-5 showed only 0.2, 3.6 and 4.2% pull-down, respectively,
whereas NHA-12 showed 18%. Thus NHA-12a, NHA-12b and NHA-5 showed only 1.1, 20 and 23% binding, respectively, to GST-PIWI
compared to NHA-12 as 100%. NHA-TNR and NHA-10 served as negative and positive controls respectively. Asterisk, non-speciﬁc bands.
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et al. (26) efﬁciently bound to GST-PIWI as evidenced by
up to 85% pull-down of the input protein (Figure 2C).
NHA-TNR, previously shown not to bind to
GST-PIWI, served as a negative control in this experiment
(25). When NHA-5 was compared to NHA-12, only
4.2 versus 18% bound to GST-PIWI representing 23%
relative efﬁciency. The very weak binding of this
C-terminal GW182 fragment 5 to Ago2 might explain
why this interaction was not reported in previous studies
(14). In order to further characterize whether the inter-
action between GST-PIWI and NHA-12 or NHA-5
was RNA dependent, whole cell lysates were harvested
24h post-transfection and treated with or without
MNase prior to the pull-down assay. RNA degradation
was monitored by 18S and lamin A/C RNA levels using
qRT–PCR (Supplementary Figure S2A). The interactions
of NHA-12 and -5 with GST-PIWI were shown to be
RNA independent (Supplementary Figure S2B). Taken
together, these data showed that the Ago hook domain
was neither critical for 12-induced repression in the
tethering assay nor important for optimal binding to
Ago2. Its full function may rely on the tertiary structure
and its relationship to adjacent Ago-binding sites. The
RRM in 5 contributed to the full repression activity
and 5 interacted with Ago2 relatively weakly when
compared with 12.
Reducing endogenous repressor levels did not affect
reporter repression induced by "12 and "5
Although it was demonstrated earlier that Ago2 protein
was not required for tethered GW182-mediated repression
in the tethering function assay (13,25,31), it was still
possible the repression mediated by 12 or 5 relied on
recruitment of other important factors of the miRNA
pathway machinery, including endogenous GW182
paralogs. This possibility was tested in a series of tethering
assays in HeLa cells where siRNA knockdown was used as
an approach to evaluating the roles of GW182 and/or
TNRC6B in the repression mediated by 12 or 5. To
knockdown endogenous GW182, a pool of three siRNAs
targeted to GW182 mRNA, but not 12 and 5, was
used as described in ‘Materials and Methods’ section.
The other two factors examined were RCK/p54 and
TNRC6B, both of which are reported to be important
for miRNA function. For example, knockdown of
RCK/p54 impaired miRNA function (47) and tethered
RCK/p54 (48,49) or TNRC6B (17,24,28) induced transla-
tional repression effects. Since HeLa cells expressed both
GW182 and TNRC6B but only very low levels of
TNRC6C compared to A549 or HEK293 cells
(Supplementary Figure S3), knockdown of both GW182
and TNRC6B together was also performed to create a
‘GW182-free’ background in HeLa cells. The luciferase
activity in each knockdown experiment for NHA-12 or
NHA-5 tethering was normalized to the same siRNA
transfected control NHA group. With  70% reduction
of endogenous GW182 or TNRC6B mRNA levels
compared to mock transfected or siGFP transfected
controls (Figure 3B, C and D), the repression effects of
tethered 12 and 5 were not altered signiﬁcantly
(Figure 3A; t-test P-value>0.05 between siGFP and
other siRNA knockdown in both NHA-12 and
NHA-5 groups). Efﬁcient knockdown of GW182,
TNRC6B and RCK/p54 was monitored by either qRT–
PCR or western blot (Figure 3B–E). An addition control
experiment was performed to monitor the effects of
siGW182 and siGW182/siTNRC6B knockdown in the
tethering assay using NHA-TNGW1, NHA-12, or
NHA-5. Supplementary Figure S4 shows the siRNA
transfection signiﬁcantly affected the reporter silencing
induced by NHA-TNGW1, but not NHA-12, or
NHA-5, as would be expected since by design the
Figure 3. Knockdown of endogenous repressors did not affect repres-
sion activity of the two deﬁned domains 12 and 5 in the tethering
assay. (A) Repression by 12 and 5 were not signiﬁcantly altered
when GW182, TNRC6B, GW182/TNRC6B, or RCK/p54 was
knocked down by respective siRNAs. Results are expressed as
mean±standard error from three independent experiments. There is
no statistical signiﬁcance difference comparing each knockdown to
siGFP within NHA-12 or -5 group (NS, t-test). Efﬁciency of
siRNA knockdown was monitored in each individual experiment
using qRT–PCR for GW182 (B), TNRC6B (C–D) compared to the
untreated HeLa cell control, or western blot analysis for RCK/p54
compared to siGFP transfected controls (E). The extract from cells
transfected with NHA and siGFP was loaded at three concentrations
(100, 50 and 25%) to demonstrate the semi-quantitative detection of
RCK/p54.
Nucleic Acids Research,2011, Vol.39, No. 7 2539siRNAs targeted endogenous GW182/TNGW1/TNRC6B
and the NHA-TNGW1 construct but not NHA-12 or
NHA-5. The apparently reduced repression effects in
both 12 and 5 tethering assay compared to data
shown in Figures 1 and 2 might be resulted from the intro-
duction of siRNA transfection. In summary, knockdown
of endogenous repressors GW182, TNRC6B and RCK/
p54 did not signiﬁcantly affect the repression activities of
12 and 5 in tethering assay. Our ﬁndings are in agree-
ment with those previously described in Drosophila (18)
and further emphasizes the independence of GW182 in
inducing translation silencing in human cells.
"5, not "12, enhanced Ago2-mediated repression in
tethering function assay
Since both 5 and 12 have comparable silencing activ-
ities when tethered to the luciferase reporter 30-UTR
(Figures 1 and 2) and none of the known endogenous
factors tested was required for their repression function,
it remained unclear whether their mechanisms of inducing
repression were similar. Therefore, experiments were
designed to determine whether the expression of 5 and
12 as a GST-tag fusion proteins could interfere with
NHA-Ago2 tethered assays, as shown in Figure 4. As
expected, the positive control NHA-TNGW1 typically
showed 85–90% repression expressed as a reduction of
luciferase activity compared to the NHA control when
tethered to the RL-5BoxB reporter (13). There was also
the typical  60% repression compared to the NHA
control when NHA-Ago2 was tethered to the RL-5BoxB
reporter (13,40). Interestingly, there was signiﬁcantly
(33%) enhanced repression with the co-expression of
GST-5 (Figure 4A, *, t-test, P<0.01, n=3). In
contrast, signiﬁcant differences were not observed for
co-expression of GST-12, -Ago2 or -QN (Figure 4A).
Furthermore, neither GST-5 nor –12 co-expression
affected repression in the tethering assay utilizing
NHA-GW182 or NHA-TNGW1 (data not shown).
Figure 4. 5, but not 12, enhanced Ago2-mediated repression in the tethering function assay. (A) Co-expressing GST-5 with NHA-Ago2 that
was tethered to the RL-5BoxB reporter enhanced the NHA-Ago2-mediating repression from 60 to 80% (33% enhanced repression). In contrast,
co-expression of GST-12, -QN, or -Ago2 did not show signiﬁcant change. Results are expressed as mean±standard error from three independent
experiments. Asterisk represents t-test compared NHA-Ago2+GST-5 with NHA-Ago2 alone, P<0.01. (B) Identical experiments as in (A) except
GFP-tagged proteins were used in place of GST fusion proteins. Results are expressed as mean±standard error from three independent experiments.
Representative cell lysates were analyzed by western blot to demonstrate expression of NHA-Ago2 and GFP fusion proteins with tubulin expression
shown as loading controls. Asterisk represents signiﬁcant difference in t-test compared NHA-Ago2+GFP-5 with NHA-Ago2 alone, P<0.01.
2540 Nucleic Acids Research, 2011,Vol.39, No. 7Since both NHA-GW182 and NHA-TNGW1 consistently
showed the highest levels of repression, it was not likely
that any further enhancement could be observed for
GST-5 or GST-12. Similar signiﬁcantly enhanced re-
pression for NHA-Ago2 was observed by co-expression of
GFP-5 but not GFP-12 (Figure 4B) indicating the
effect is not related to the GST tag. The 5-mediated en-
hancement in repression by NHA-Ago2 implied that this
could be due to binding to other translational machinery
or RNA decay factors that remain to be determined.
Although 12 strongly bind to Ago2, it did not affect
repression by tethered Ago2.
"12, not "5, interfered with endogenous miRNA
repression
In our previous study, it was shown that multiple GW182
regions (1, 5 and 12) were able to bind Ago proteins
(25). Thus, the next experiment was to examine whether
these three Ago-binding regions would interfere with en-
dogenous miRNA function in a dominant-negative
manner. The RL reporter for miR-20 (RL-20 bulge),
which contains seven miR-20 target sites and forms
bulge structures with miR-20 (44), was used to monitor
the cellular miR-20 functional status. In normal condi-
tions, the expression of RL-20 bulge is inhibited by the
endogenous basal miR-20 (44, data not shown). To our
surprise, when GST-TNR, –1, –12, or –5 were
co-transfected with the RL-20 bulge reporter using the
dual luciferase system, only GST-12 increased the ex-
pression of RL-20 bulge in all three conditions when
increasing amounts of GST plasmids were used
(Figure 5A). The results showed that although 1, 12
and 5 were able to bind Ago protein, only 12 impaired
miR20-induced repression with >3-fold increase in
luciferase activity (P<0.0001) and 1 showed mild
release of RL-20 bulge reporter silencing (P<0.01).
As already shown in Figure 2, the Ago hook in 12 was
neither critical for 12-induced repression in a tethering
assay nor responsible for maximum binding with Ago2.
Therefore, the next question was whether the Ago hook
domain could be responsible for the miRNA interference
effect or de-repression observed for 12. To also avoid
any potential tag-dependent effects when only GST-tag
was used, NHA-tagged constructs including 12a and
12b were employed to repeat the experiment.
Meanwhile, another RL reporter with miR-20 target
sites forming perfect match with endogenous miR-20,
thus acting as reporter for the siRNA pathway, was
utilized to determine whether this interference also
applies to the siRNA pathway. The results clearly
showed that 12a, which lacked the Ago hook, retained
almost the same capability to interfere with RL-20 bulge
reporter miRNA function (Figure 5B, left panel,
P<0.001). However, 12b, which contained the Ago
hook domain, mildly altered the miR20-induced repres-
sion (Figure 5B, left panel). This interference was only
observed with the RL-20 bulge but not the RL-20
perfect reporter, thus demonstrating overexpression of
12 and its deletion constructs impaired reporter silencing
in a miRNA-speciﬁc manner. Compared to the RL-20
bulge reporter, the RL-20 perfect reporter showed
enhanced repression effects from efﬁcient mRNA degrad-
ation induced by the siRNA machinery and it therefore
served as a useful functional control. Note that 12b
bound to Ago2 more efﬁciently than 12a (Figure 2C)
and yet its miRNA interference effect was weaker,
indicating there were additional factors involving in
interfering this miRNA-mediated silencing. This led us
to further examine the role of GW/WG motifs residing
in this fragment by generating mutations of those motifs.
Figure 5. 12 signiﬁcantly interfered with endogenous miRNA repression. (A) GST-12, but not GST-5, interfered with miR-20-mediated re-
pression. Three different amounts (0.6, 0.3 and 0.15mg) of GST-TNR, -1, -12 and -5 plasmids were co-transfected with the RL-20 bulge
reporter into HEK293 cells. The RL-20 bulge expression was signiﬁcantly increased when cells co-expressed 12. Overexpression of 1 also mildly
interfered with miRNA function. Asterisk represents signiﬁcant difference in t-test compared with +GST-TNR, P<0.01, n=3; Double asterisks
represent highly signiﬁcant difference in t-test compared with+GST-TNR, P<0.0001, n=3.(B) 12 and its deletion constructs only interfered with
miRNA but not siRNA mediated repression. NHA tag, NHA-TNGW1, -12, -12a, -12b and -5 were co-transfected with reporters RL-20
bulge/FL or RL-20 perfect/FL in HEK293 cells. Compared to the NHA control, the relative activity of RL-20 bulge was signiﬁcantly increased in
cells expressing NHA-12 and -12a/b but not in cells expressing -TNGW1 or -5. NHA-12 and its deletion constructs did not interfere with
RL-20 perfect reporter that repressed by siRNA pathway. Results are expressed as mean±standard error from three independent experiments.
Asterisk represents signiﬁcant difference in t-test compared with +NHA, P<0.01.
Nucleic Acids Research,2011, Vol.39, No. 7 2541Substitution of GW/WG motifs with alanines in
GW1"12a hindered its tethering assay activity, as well as
its interference with endogenous miRNA repression
Since the results showed that the Ago hook was not
critical for function but 12a retained almost the same
capability to interfere with RL-20 bulge reporter, it was
postulated that the GW/WG motifs in 12a might be im-
portant for functions besides binding to Ago2
(Figure 6A). A 12a mutant (12am) was then generated
to replace all GW/WG residues in 12a with alanine–
alanine (AA) residues. In a tethering assay using
RL-5BoxB, NHA-12am was devoid of translation
silencing when compared to NHA-12a and other
relevant controls (Figure 6B). When 12am was
analyzed in the interference of RL-20 bulge reporter re-
pression, the ability of 12a to release miR-20 activity was
abolished in 12am (Figure 6C). These data suggested
that the GW/WG motifs in 12a were important for the
silencing in the tethering assay and interference in RL-20
bulge reporter function. Since it was shown that 12a did
not bind efﬁciently to Ago2 (Figure 2C), the GW/WG
motifs in 12a might be responsible for both mediating
strong repression and impairing miRNA-mediated
silencing. It appeared that the GW/WG motifs in different
regions of GW182 have different functional roles. For
example, 1 also possessed multiple GW/WG motifs
and a deﬁned Ago-binding site but it was not efﬁcient in
both tethering and RL-20 bulge interference assays
compared to 12. Furthermore, mutation of some of
the GW motifs on 1 did not abolish the Ago binding
(25). However, it is acknowledged that these mutations
may inﬂuence the global folding of the fragment and
more detailed mutagenesis is needed in future studies to
further deﬁne the roles of these GW/WG motifs.
Collectively, GW/WG motifs in 12a region showed sig-
niﬁcant effects in silencing tethered mRNA and impaired
miRNA-induced repression. GW/WG motifs located in
different regions of GW182 might have different function-
al preferences or formed a particular 3D structure that
requires further investigation.
"12 and "5 bound to PABPC1 but only mildly affecting
mRNA degradation
In the eukaryotic cap-dependent translation initiation
step, mRNAs usually form circularized structures
facilitated by the binding between the cap-binding
complex eIF4E/4G and Poly-A-binding protein PABPC1
to favor association with the 40S ribosome (50). Thus,
PABPC1 has been shown to play a critical role in
mRNA degradation (23). To determine whether the two
GW182 silencing domains 12 and 5 play differential
roles in mRNA degradation, GST pull-down experiments
were designed to investigate the interaction between
GW182 fragments with PABPC1. The positive control
7 harboring the C-terminal half of TNWG1, including
the PAM2 (DUF) domain, bound strongly to
GST-PABPC1 (Figure 7A). This data is consistent with
the results observed with TNRC6C that the PAM2
domain is the major binding site to PABPC1. 5
showed weak binding (arrow) for PABPC1 and this is
consistent with a recent report (29) describing weak
binding activity in the C-terminal region of GW182. It is
noteworthy that 12 showed intermediate binding activity
to PABPC1 compared to 7 and 5. In order to further
characterize whether the interaction between
GST-PABPC1 and NHA-12 or NHA-5 was RNA
Figure 6. Substitution of glycine (G) and tryptophan (W) residues with alanine (A) in GW112a interfered with its repression on reporter and
interference in miRNA repression activity. (A) Amino acid sequence of 12a shown with GW and WG residues are underlined; these residues are
substituted with AA to generate a mutant 12am. (B) 12am had no repression activity in RL-5BoxB tethering assay. NHA-5 and its deletion
constructs served as positive controls. Asterisk represents signiﬁcant different in t-test compared with NHA-12, P<0.01, n=3. (C) GW/GW
mutated 12a (12am) no longer affected miRNA mediated repression. Experiment was performed as described in Figure 5B. Asterisk represents
signiﬁcant difference in t-test compared NHA-12a with NHA, P<0.01.
2542 Nucleic Acids Research, 2011,Vol.39, No. 7dependent, whole cell lysates were harvested 24h
post-transfection and treated with or without MNase
prior to the pull-down assay as described in
Supplementary Figure S2. The interactions of NHA-12
and -5 with GST-PABPC1 were shown to be RNA in-
dependent (Supplementary Figure S5). To further ﬁne
mapping the PABPC1-binding sites on two GW182 re-
pression domains, additional experiments were performed
to show that subclones NHA-12b and NHA-5b were
positive in pull-down assays with GST-PABPC1
(Supplementary Figure S6). Note that the interaction of
12 and 5 with endogenous PABPC1 was not observed
potentially reﬂecting that these are weak interactions (data
not shown).
A qRT–PCR was utilized to measure the level of deg-
radation of the RL-B5Boxb reporter mRNA in tethering
assay normalized to the FL mRNA level (13). As shown in
Figure 7B, both NHA-12 and -5 induced comparable,
mild mRNA degradation when tethered to the reporter
comparable to the activities of NHA-GW182 and -
TNGW1, respectively. The observation that NHA-12
induced mild reporter mRNA degradation is consistent
with the recent report that a 12-comparable dGW182
silencing domain (amino acids 205–490, cf. dGW182)
also induced mRNA degradation in tethering assay (19).
This difference in the extent in mRNA degradation may
be explained by variations in methodology used to detect
degradation [i.e. qRT–PCR in this study versus northern
blot (19)], as well as differences in the activity of human
GW182 versus the Drosophila orthologs.
DISCUSSION
"12 and "5 mapped as two non-overlapping domains
mediating repression
Since its discovery in 2002 (11), increasing and compelling
evidence from different laboratories has shown that
GW182 and its paralogs have important functions in
miRNA-mediated translational repression, as well as
mRNA degradation (13,17–34). A summary of the func-
tional characteristics of different domains of GW182 in
this study is shown in Figure 8, where their differential
Ago2 binding, repression in tethering assays, enhancing
Ago2-mediated repression and releasing endogenous
miR-20 repression are compared and contrasted. Our
previous data showed translational repression of
tethered Ago2 to reporter 30-UTR required GW182 and
that tethered GW182 exerted a stronger repression than
tethered Ago2 (13). As exempliﬁed in the present study,
these observations led to further mapping of the function-
al repression domain(s) of human GW182 by generating a
series of deletion constructs using tethering assays. Recent
reports have shown that the C-terminal domain of human
GW182/TNGW1, TNRC6B and TNRC6C (17,24,28) and
Drosophila GW182 (18–20,22) exert strong translational
repression when tethered to the 30-UTR of the reporter
mRNA. Our current data from human GW182 truncated
constructs also support the conclusion that GW182
C-terminal fragments 7, 8 and 5 indeed inhibit
luciferase activity of the 5BoxB reporter when tethered
to its 30-UTR. Among those, 5 (amino acids 1670–
1962) was the minimum domain that retained the full
activity. It was well established by Izaurralde and col-
leagues that the M-GW and C-GW domains in the
C-terminus of Drosophila GW182 act as a bipartite
silencing domain and the RRM contributed to, but was
not required for, silencing in tethering and complementa-
tion assays (14,15,20,22). In a study of TNRC6C by
Filipowicz and co-workers (28), C-terminal mutation
and deletion constructs were generated to elucidate the
importance of the integrity of M-GW and C-GW in
silencing domains; only RRM mutations mildly affected
Figure 7. Binding of 12 and 5 to PABPC1 did not signiﬁcantly
affect reporter mRNA degradation. (A) Differential binding of
GW182 fragments 12, 7 and 5 to PABPC1. GST-PABPC1 was
co-transfected with different NHA-tagged constructs into HeLa cells as
shown above the panels for the designed GST pull-down assay. After
24h, cell lysates were harvested and analyzed by GST pull-down
followed by western blot analysis. GST-PABPC1 strongly pulled
down NHA-7 compared to NHA-12 and -5 (arrow). (B) Both
tethered 12 and 5 induced primarily translational repression with
only moderate reporter mRNA degradation. To determine the mRNA
level of the reporter in tethering assay, a pair of each RL and FL
primers was utilized in SYBR-Green qRT–PCR. The RL mRNA
level was normalized to FL mRNA. All results are expressed as
mean±SD from three independent experiments. Asterisk represents
signiﬁcant difference in t-test compared with NHA, P<0.01. No sig-
niﬁcant difference observed in mRNA degradation for any of the con-
structs compared with NHA.
Nucleic Acids Research,2011, Vol.39, No. 7 2543the repression tethered to 30-UTR. Our data of human
GW182 supported these observations by showing the re-
pression activity of 5a with the RRM and C-GW
deletion was impaired but still maintained  50% repres-
sion through the M-GW. 5b with the C-terminal 5
deletion but containing intact M-GW, RRM and C-GW
retained full repression activity.
In contrast to reports to date, the current study
demonstrated that another repression region 12 (amino
acids 896–1219), in the middle region of human GW182
appear to be crucial for this repression function. This is
the ﬁrst time that the functional repression domain 12 is
identiﬁed within the described ‘N-terminal Ago-binding
domain’ (Figure 8) of human GW182. However, it
should be noted that some TNRC6C fragments such as
amino acids 1–405 or 1–1304 have been shown to be par-
tially active with  50% repression activity in tethering
assays (28). Our data ruled out the Ago hook as a
critical region for repression activity. Since the Ago
hook domain was deﬁned in binding the Ago PIWI
domain both in vitro and in vivo (34), a number of
recent studies showed that additional Ago
hook-independent GW182 fragments could efﬁciently
bind Ago protein in human GW182, TNRC6B and
TNRC6C as well as dGW182 (17,20,24–26). For
example, the report of Takimoto et al. (26) identiﬁed
three deﬁned Ago2-binding domains that corresponded
to amino acids 697–739, amino acids 969–1031 and
amino acids 1059–1163 (Figure 8). It has also been
shown that deletion of the Ago hook in GW182 and
TNRC6C did not totally abolish the binding to Ago
proteins (24). Chekulaeva et al. (18) observed that three
dGW182 regions were responsible for the repression in
Drosophila. The ﬁrst repression region was the
C-terminal domain of dGW182; the second repression
region was the N-terminal domain amino acids 1–605
(cf. dGW182); the third region (amino acids 605–830, cf.
dGW182), including the QN rich region, also triggered
repression. We note that comparable activity for the cor-
responding region in human GW182 was not observed in
our present study, an inconsistency that could be due to
paralog- or species- speciﬁc effects. During the prepar-
ation of this manuscript, Chekulaeva et al. (19) published
a report showing the functional signiﬁcances of GW/WG
repeats on dGW182 repression domain (amino acids
205–490) that induced reporter silencing. These investiga-
tors showed alignment of their repression domain with
other GW182 homologs and found that mutation of
certain conserved amino acid residues abolished repres-
sion induced by these dGW182 fragments. Interestingly,
the alignment showed the second dGW182 repression
domain corresponded closely to 10 (amino acids
655–1343). In agreement with this ﬁnding, 10 induced
repression in our tethering assay was clearly observed
(Figure 1). In addition, the 12 repression domain
deﬁned in our study represents a new core repression
region with somewhat higher repression than in 10
(Figure 1, 12 versus 10).
In order to investigate whether the repression effects
caused by these fragments were direct or indirect,
knockdown-tethering experiments utilizing endogenous
GW182, TNRC6B, or RCK/p54 did not dramatically
Figure 8. Summary of GW182 domain functional characteristics. DUF, sequence identiﬁed to be important for PABPC1 binding. A reference
schematic map of TNGW1 in one recent review (15) is included for comparison. UBA, Ubiquitin-associated domain; PAM2, PABP-interacting motif
2. Regions M1 and M2 together with PAM2 formed the Mid region. Middle region and C-terminal region but not RRM deﬁned the bipartite
silencing domain.
2544 Nucleic Acids Research, 2011,Vol.39, No. 7impair the 5BoxB reporter repression tethered by 12 or
5. Thus, our study shows that there are two functionally
independent repression domains in human GW182 with
differences discussed further in the next paragraph. It is
possible that 5 has a more important and more direct
repression function than 12 because of the apparent
higher tethering activity (Figures 1 and 3A) and its
ability to enhance Ago2-mediated repression in a tethering
assay (Figure 4). However, since it is still unclear how
these domains bind in vivo, it can be argued that 12
can play an equally important role.
GW182 has been shown to bind multiple Ago–miRNA
complexes (20,24–26). Studies have showed that closely
spaced miRNA target sites often act synergistically and
result in stronger repression than those separated by
greater distances (36). The demonstration that there is
more than one repression domain in each molecule of
GW182 as described in this study and described by
others in Drosophila (18,19), suggests that re-examination
is in order to elucidate how enhanced repression may be
triggered when miRNA sites are approximated to each
other in 30-UTRs. The functional advantages of the
dual-repression domain GW182 with 12 and 5
having their own functional bias requires elucidation. It
is conceivable that GW182, and perhaps its paralogs,
function best to regulate mRNA with multiple
miRNA-binding sites. Future studies will need to
address the molecular mechanism how mRNAs with
multiple putative miRNA-binding sites will beneﬁt the ef-
ﬁciency of regulation in concerted manners.
GW182 mediated translational repression distinguished
from mRNA deadenylation and decay
MicroRNAs bind primarily to the 30-UTR of their target
mRNA, and mediate translational repression and/or
mRNA decay, although the detailed molecular mechanism
is still not completely understood. Several models have
been proposed indicating that translation repression is
achieved by inhibition of translational initiation, elong-
ation, or mRNA deadenylation (1,5). A recent report
utilizing in vitro translation extracts from mouse Krebs-2
ascites cells showed miRNA-mediated deadenylation
occurred 1–2h after initial translational inhibition (23).
These investigators and others also showed that the
C-terminal domain of GW182 bound to deadenylases
through the DUF conserved domain located between the
QN-rich domain and the RRM domain (23,29) [also
known as PAM2 domains (15), see Figure 8] and recruited
deadenylases to the target mRNA. This deadenylation
process requires binding of Ago2 and GW182 paralogs
and this binding appears to be RNA independent (23).
Similar results have been observed in mouse 3T3 cells
where it was shown that when mRNA is bound by
miRNA, a two-step deadenylation takes place followed
by decapping (30). In Drosophila S2 cells, the DUF
domain of dGW182 binds to PABPC1 and thus
competes for eIF4G binding and leading to the disruption
of the circularized mRNA structure that would normally
favor translation (27). It is proposed that PAM2, M2
(between PAM2 and RRM) and C-terminal region on
dGW182 together deﬁne a binding region to PABPC1
(15,27) (Figure 8). In contrast, PAM2 on TNRC6C
appears to be the major binding site for its interaction
with PABPC1 (15,23). Another weak PABPC1-binding
site was subsequently identiﬁed on the TNRC6C
C-terminal domain downstream from the RRM (29).
These recent data indicate that there are differences in
GW182–PABPC1 complex formation when different
GW182-related proteins are compared. Of relevance to
the present study, both 5 and 12 domains lack the
known PABPC1-binding domain DUF (Figure 8) but
still caused remarkable repression in a tethering assay
and exhibited enhanced Ago2-mediated repression when
compared to 7o r8 that contains the DUF domain.
GST pull-down assays indicated 7 strongly bound to
PABPC1 whereas both 12 and 5 bind weakly to
PABPC1 (Figure 7B); nevertheless, these reactivities with
PABPC1 appeared speciﬁc as several other controls
including 1, which binds Ago2, were negative. Thus, it
is interesting that the two deﬁned repression domains,
lacking DUF, somehow still associated with PABPC1. It
can be speculated that when mRNA is bound by speciﬁc
miRNA–Ago complex, translational inhibition occurs
relatively rapidly and is mediated by one or the other re-
pression domains of GW182 (or from its paralogs), but
the deadenylation step can be delayed. This process may
be reversible within a narrow time frame and the repressed
mRNA still may be released for further translation.
Whether 12 and 5 play a role in this control will
need further study. Our study demonstrated that human
GW182 repression domains can be clearly separated from
the putative PABPC1-binding domain DUF.
Distinct characteristics of "12 and "5 implying
differential functions for GW182?
It has been shown by us (25,32) and others (20,24,26) that
the N-terminal and middle region of the GW182 family
and dGW182 possess multiple Ago2-binding sites. Our
co-Immunoprecipitation experiments showed that 12
bound strongly to Ago2, while 5 had a substantially
lower afﬁnity for Ago2. Co-expression of 12, but not
other GW182 fragments such as 5, 1, 11, or TNR,
signiﬁcantly inhibited miRNA rather than siRNA activity,
as determined by the difference between activity of RL-20
bulge and RL-20 perfect miRNA reporters, although 1,
5 and 11 still bind to Ago2. The impairment of
miRNA function following overexpression of dGW182
or human GW182 paralog fragments that bind Ago has
been reported. For example, overexpression of the
N-terminal half of Drosophila GW182, which bind Ago1
protein, impaired miRNA function and the impairment
was rescued by overexpression of Ago protein (21).
Other data showed that synthetic peptides or recombinant
proteins corresponding to the Ago hook domain impaired
translational efﬁciency in an in vitro translation assay (34)
or impaired miRNA-mediated deadenylation (23). In par-
ticular, let-7-mediated translational repression is inhibited
by a GW182 fragment containing multiple Ago2-binding
sites in vitro (26). As summarized in Figure 8, clearly there
are distinct properties of 12 and 5.
Nucleic Acids Research,2011, Vol.39, No. 7 2545Why did 5 enhance Ago2 repression effects in the
tethering assay but have no apparent effect on miR-20
repression? Why did 12 abolish miR-20 repression, but
not the siRNA-like repression by miR-20, or affect Ago2
repression in tethering assay? Clearly, more studies are
needed to address these questions. Speculations on the
potential implication of these questions will undoubtedly
stimulate discussion, debate and future research direc-
tions. GW182 was identiﬁed as a marker for cytoplasmic
foci GW/P bodies (11) and it is likely that there is a certain
amount of ‘soluble’ cytoplasmic pool versus ‘GW/P
body-bound insoluble’ pool of this protein. The distribu-
tion between the two putative pools has not been studied
extensively as there are many factors that may inﬂuence
this dynamic process. For example, transfection of siRNA
into culture cells (45) or lipopolysaccharide stimulated
monocytes (51) cause an increase in number and size of
these foci and probably switch GW182 from the soluble to
the insoluble pool. In contrast, induced cell quiescence
(12) or blocking the biogenesis of miRNA (52) lead to
disassembly of GW/P bodies and increases in the soluble
pool of GW182. A technical consideration is that, the sep-
aration of soluble versus insoluble pool also likely depends
on the composition of the lysis buffer including whether
commonly used detergents are used. The signiﬁcance of
the two distinct repression domains in GW182 and their
relationship to two or more cytoplasmic pools also
deserves consideration. Whether certain GW182 can
exert inhibition of repression as demonstrated by trans-
fected 12 in miR-20 repression will also need to be
explored.
In conclusion, this study identiﬁed two distinct repres-
sion domains in GW182 using tethering assays and
showed their characteristics in different functional
assays. Observations that GW182 is characterized by
having multiple Ago-binding sites with different binding
afﬁnities, as well as two distinct repression domains, is
highly suggestive of its role in stabilizing multiple ‘re-
pressed’ Ago–miRNA–mRNA complexes or in
aggregating Ago–miRNA–mRNA complexes to establish
an efﬁcient repressed state. Alternatively, our data also
suggest that GW182 may regulate the fate of repressed
mRNA and potentially direct the repressed complex to
decay or reversal to a translational state.
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